Skip to main content
MedPathMedPath Home
Clinical Trials/TCTR20210303009
TCTR20210303009
Completed
Phase 4

Efficacy of Sublingual administration Misoprostol 600 mcg versus 800 mcg for induced abortion in women with early pregnancy loss: A Randomized Controlled Trial

o0 sites105 target enrollmentMarch 3, 2021
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsPregnant women which gestational age less than 12 weeks with early pregnancy loss.Early pregnancy lossMedical abortionMisoprostol

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Pregnant women which gestational age less than 12 weeks with early pregnancy loss.
Sponsor
o
Enrollment
105
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

There was no significant difference in success rate between 2 groups, however, the 800 mcg misoprostol was higher rate of success and side effects were not different to 600 mcg group

Registry
who.int
Start Date
March 3, 2021
End Date
January 31, 2021
Last Updated
last year
Study Type
Interventional
Sex
Female

Investigators

Sponsor
o

Eligibility Criteria

Inclusion Criteria

  • •18\-year\-old pregnant women who were below 12 weeks of gestational age and diagnosed with an early pregnancy loss with stable vital signs, closed internal cervical os, no contraindication for misoprostol, no active bleeding, no abnormal pregnancy (ectopic pregnancy, molar pregnancy) were included

Exclusion Criteria

  • •Women who were not able to follow up were excluded from this study.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 2
Comparing the effect of sublingual Misoprostol versus intravenous Oxytocin in the management of the third stage of laborintrapartum haemorrhage.Other intrapartum haemorrhage
IRCT138902293964N1Research vice chancellorship - Guilan university of medical sciences200
Not yet recruiting
Phase 4
A clinical trial to study effect of two drugs,sublingual misoprostol and intravenous Trenaxamic acid in primary lower segment cesarean section patients to estimate the amount of blood lossHealth Condition 1: O94-O9A- Other obstetric conditions, not elsewhere classified
CTRI/2021/03/032275Aarupadi Veedu Medical College and Hoppital
Recruiting
Phase 4
A clinical trial to study the effects of two drugs, Misoprostol and Dinoprostone Gel in induction of labour at more than 37 weeks of PregnancyHealth Condition 1: O80- Encounter for full-term uncomplicated delivery
CTRI/2023/07/054780Gujarat Adani Institute of Medical Sciences
Completed
Phase 2
Comparison of Effects of Sublingual Misoprostol and Infusion Oxytocin in Reduction of Bleeding at CesareaChild birth and priperium.O60-O75O00-O99
IRCT201109104025N4Vice chancellor for research of Kermanshah University of Medical Sciences180
Completed
Not Applicable
Comparison between use sublingual misoprostol and blood loss during myomectomyterine myoma.Other specified noninflammatory disorders of uterus
IRCT2014071414621N1Deputy of Research- Iran University of Medical Sciences64